Home
Home

Nektar

Nektar Posts Wider Loss, Maintains View

Nektar Posts Wider Loss, Maintains View
Yahoo/Zacks

Nektar Therapeutics Increases Sales but Misses Estimates on Earnings

Nektar Therapeutics Increases Sales but Misses Estimates on Earnings
Motley Fool

Why AstraZeneca Will Disappoint In 2013

Why AstraZeneca Will Disappoint In 2013
Seeking Alpha

3 Things to Watch With Nektar Therapeutics

3 Things to Watch With Nektar Therapeutics
Motley Fool

This Week in Biotech: Part 2

This Week in Biotech: Part 2
Motley Fool

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week
Motley Fool

Why Nektar Therapeutics' Shares Tumbled

Why Nektar Therapeutics' Shares Tumbled
Motley Fool

Here's Why Nektar Therapeutics's Latest Report Might Worry You

Here's Why Nektar Therapeutics's Latest Report Might Worry You
Motley Fool

Four Important Biotech Stocks Targeting Unmet Needs

Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool

3 Reasons Pfizer Should Partner With MannKind

3 Reasons Pfizer Should Partner With MannKind
Motley Fool